02 jan: LR Realkredit A/S - Ekstraordinære indfrielser (CK93)
02 jan: TRANSAKTIONER I FORBINDELSE MED AKTIETILBAGEKØBSPROGRAM
02-01-2019 10:05:26

Establishment permit and power purchase agreement delayed on Taiwanese offshore wind projects

In April 2018, Taiwan’s Ministry of Economic Affairs awarded Ørsted the right to install 900MW offshore wind from its Changhua 1 and 2a projects in 2021.

In accordance with Taiwan Civil Code, the deadline for signing the 2018 power purchase agreement (PPA) was extended to 2 January 2019. As Taiwan’s Bureau of Energy has not issued an establishment permit for the projects by close of business local time, it is no longer possible for Ørsted and the Taiwanese utility Taipower to sign a 2018 PPA for Changhua 1 and 2a.

The 2019 feed-in-tariff has not been decided yet. However, in November 2018 the Taiwanese government proposed a 2019 feed-in-tariff of TWD5,106 (approx. EUR145) per MWh and suggested a production cap of 3,600 annual full-load hours.

Martin Neubert, CEO, Ørsted Offshore, says:

“We’re disappointed with the process and the delay of the establishment permit and PPA. We will now pause and revisit all our project activities, the timeline of the projects, and our supply chain commitments and contracts as we had assumed signing of the PPA in 2018. We’re very concerned about the suggested feed-in-tariff level for 2019 as well as the newly proposed cap on annual full-load hours. We will need to see significant changes to these proposals before we can progress any further towards a final investment decision on the projects.”

The feed-in-tariff needs to reflect the extraordinarily high costs faced by Greater Changhua 1 and 2a, mainly related to creating a local supply chain at scale, reinforcing the onshore grid infrastructure and building, operating and maintaining offshore wind farms in challenging waters where typhoons and earthquakes occur.

“The proposed retrospective changes would jeopardise the creation of a local offshore wind supply chain, harm the planned transition to renewable energy and cause significant uncertainty among international investors looking to Taiwan. Only with a stable and predictable policy framework, Taiwan has the potential for developing large-scale clean power production while creating thousands of local jobs and becoming a hub for offshore wind in Asia-Pacific,” says Martin Neubert.

The information provided in this announcement does not change Ørsted’s previous financial guidance for the financial year of 2018 or the announced expected investment level for 2018.

About Ørsted in Taiwan

  • In April 2018, Taiwan awarded Ørsted the right to connect 900MW offshore wind to Taiwan’s power grid in 2021 from Ørsted’s Greater Changhua sites.

     

  • In June 2018, Ørsted won the right to build an additional 920MW offshore wind capacity from its Greater Changhua sites. Subject to Ørsted’s final investment decision, these projects will be built in 2025.

     

  • Ørsted’s Greater Changhua projects comprise a total potential offshore wind capacity of 2.4GW. Approx 1.8GW have now been earmarked for buildout in 2021 and 2025, and the remaining approx 0.6GW can participate in future auction rounds. 

     

  • Ørsted is also the co-owner of Taiwan’s first commercial-scale offshore wind project, Formosa 1, which will be extended from its current 8MW capacity to 128MW in 2019.

As the world leader in offshore wind, Ørsted operates more than 1,100 offshore wind turbines. Ørsted has installed approx 5.6GW offshore wind capacity and has a further 3.4GW under construction. In addition, Ørsted has secured the rights to build approx 1GW offshore wind in the US by 2023, approx 1.1GW in Germany by 2025, and approx 1.8GW in Taiwan. It is Ørsted’s ambition to have installed a total of 15GW offshore wind capacity worldwide by 2025.

For further information, please contact

Ørsted Group Media Relations

Tom Lehn-Christiansen

+45 99 55 60 17

tomlc@orsted.dk

Ørsted Asia Pacific Media Relations

Christy Wang

+886 905 529 280

chrwa@orsted.com

Ørsted Investor Relations

Daniel Lerup

+45 99 55 97 22

danil@orsted.dk  

Attachment

logo.png

Relateret indhold
25 jun - 
Ørsted lægger to enheder sammen: Koncerndirektør forlad..
24 jun - 
Mandagens aktier: Ørsted til vejrs på USA-nyt i svagt n..
24 jun - 
Aktier/middag: Danske Bank bankes ned efter farvel til ..
Relateret debat
23 jun - 
Ja, det virker bevidst at de undgår Vestas/MHI, gad vid..
21 jun - 
Godt for Dansk omdømme inden for Havvind. Vi er førende..
21 jun - 
Burde kunne give lidt medvind mandag: Ørsted sejrer i N..
Del

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
21 jun
ORSTED
  Burde kunne give lidt medvind mandag: Ørsted sejrer i New Jersey: Foretrækkes til 1,1 GW havvind -..
6
21 jun
ORSTED
Godt for Dansk omdømme inden for Havvind. Vi er førende på viden der. Som vestas aktionær kan det g..
3

Lars Christensens Verden - Episode 23: Sådan bruger danskerne deres penge

26-06-2019 12:10:56
I denne episode af “Lars Christensens Verden” får du svar på, om der er forskel på kvinders og mænds investeringsadfærd, hvorfor unge mænd bruger så mange penge på gambling, og hvorfor kvinder burde investere mere i aktier.Ugens gæst, privatøkonom og senioranalytiker Louise Aggerstrøm Hansen, Danske Bank, deler sine mange indsigter i de private husholdningers økonomiske adfærd, forbrugsmønstre og ..

Investeringsfirma øger shortpositioner i danske banker

26-06-2019 15:22:53
Investeringsselskabet Merian Global Investors UK har øget sit sats på kursfald i Sydbank og Jyske Bank.Det fremgår af meddelelser fra Finanstilsynet onsdag.Merian Global Investors holder nu 0,60 pct. af aktiekapitalen i Sydbank mod en tidligere shortposition på 0,51 pct. På samme tid har investeringsselskabet øget sin shortposition i Jyske Bank til 0,71 pct. af den samlede aktiekapital fra en posi..

Novo-konkurrent vil have højdosisudgave af Trulicity på markedet

26-06-2019 13:10:48
Det amerikanske medicinalselskab Eli Lilly, der er en af danske Novo Nordisks store konkurrenter, har haft succes i et nyt studie med sin ugentlige GLP-1-analogen Trulicity i højdosisudgaver på 3 og 4,5 milligram.Midlet er i forvejen på markedet i en dosis på 1,5 milligram og konkurrerer med Novo Nordisks midler Victoza og Ozempic.I et studie når højdosisudgaverne af Trulicity til behandling af pa..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Danske Bank-direktør rykker til Nordea
2
SEB løfter sin anbefaling på Novo Nordisk
3
Norwegian lukker tre ruter ud af København i vinterprogrammet
4
Aktier/tendens: Bankerne skal forsøge at rette sig i svagt marked
5
ABG om Ambu: Topchefs køb af aktier sender et godt signal til markedet

Relaterede aktiekurser

Ørsted A/S 582,20 -1,1% Fald i aktiekurs

Copyright Berlingske Media 2019  Handelsbetingelser  |  Cookiedeklaration  |  Cookie- og Privatlivspolitik  |  Ophavsret og vilkår
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
27. juni 2019 02:22:49
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20190527.1 - EUROWEB6 - 2019-06-27 02:22:49 - 2019-06-27 02:22:49 - 1 - Website: OKAY